Evidence map›Paper›PMID 41420061›Full record

ArticleNature microbiology2026

Streptococcus pneumoniae S protein activates PBP1a to regulate peptidoglycan remodelling and cell division.

Hugo Millat, Cassandra Falcou, Cassandra Lenoir, Nicholas S Briggs, Jack Stone, Pierre Simon Garcia, Sylvie Manuse, Caroline Cluzel, André Zapun, Cécile Morlot and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. A broadly conserved gram-positive lipoprotein regulates cell elongation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hugo MillatMolecular Microbiology and Structural Biochemistry (MMSB), Univ. Lyon 1, CNRS UMR 5086, Lyon, France.
Cassandra FalcouMolecular Microbiology and Structural Biochemistry (MMSB), Univ. Lyon 1, CNRS UMR 5086, Lyon, France.
Cassandra LenoirMolecular Microbiology and Structural Biochemistry (MMSB), Univ. Lyon 1, CNRS UMR 5086, Lyon, France.
Nicholas S BriggsSchool of Life Sciences, University of Warwick, Coventry, UK.
Jack StoneSchool of Life Sciences, University of Warwick, Coventry, UK.
Pierre Simon GarciaAix-Marseille Univ., CNRS, LCB, UMR 7283, IMM, Marseille, France.ORCID http://orcid.org/0000-0001-7444-899X
Sylvie ManuseMolecular Microbiology and Structural Biochemistry (MMSB), Univ. Lyon 1, CNRS UMR 5086, Lyon, France.
Caroline CluzelLaboratoire de Biologie tissulaire et Ingénierie Thérapeutique (LBTI), Univ. Lyon 1, CNRS UMR 5305, Lyon, France.ORCID http://orcid.org/0000-0001-8946-3439
André ZapunUniv. Grenoble Alpes, CNRS, CEA, IBS, Grenoble, France.
Cécile MorlotUniv. Grenoble Alpes, CNRS, CEA, IBS, Grenoble, France.ORCID http://orcid.org/0000-0002-9295-1035
David I RoperSchool of Life Sciences, University of Warwick, Coventry, UK.ORCID http://orcid.org/0000-0003-0009-621X
Adrien DucretMolecular Microbiology and Structural Biochemistry (MMSB), Univ. Lyon 1, CNRS UMR 5086, Lyon, France.ORCID http://orcid.org/0000-0002-9076-405X
Christophe GrangeasseMolecular Microbiology and Structural Biochemistry (MMSB), Univ. Lyon 1, CNRS UMR 5086, Lyon, France. christophe.grangeasse@cnrs.fr.ORCID http://orcid.org/0000-0002-5484-4589

Funding

Agence Nationale de la Recherche (French National Research Agency) ANR-19-CE15-0011Agence Nationale de la Recherche (French National Research Agency) ANR-20-CE07-0012Agence Nationale de la Recherche (French National Research Agency) ANR-23-CE11-0029Agence Nationale de la Recherche (French National Research Agency) ANR-24-CE11-4058 to CGRCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/Y003187/1RCUK | Medical Research Council (MRC) MR/Z504245/1
6 · The paper itself

Abstract

Class A penicillin-binding proteins (aPBPs) are involved in the biosynthesis and remodelling of peptidoglycan (PG). The human bacterial pathogen Streptococcus pneumoniae produces three aPBPs, which are regulated to maintain the bacterium's ovoid shape. Evidence suggests that PBP1a and PBP2a activities are closely coordinated; however, their precise functions remain unclear. Here we characterized the pneumococcal S protein, which contains a LysM-PG-binding domain and a GpsB-interacting domain. Using S protein fusion constructs or mutant bacterial strains, we show that S protein localizes to the division ring and is required to prevent premature cell lysis and minicell formation due to aberrant division site placement. S protein interacts with PBP1a and activates its PG synthesis activity. Co-immunoprecipitation experiments combined with biochemical, genetic, structural prediction and microscopy analyses suggest that S protein is part of a larger multiprotein complex containing aPBPs and PG-modifying enzymes, and coordinated by the scaffolding protein GpsB. Together, these findings suggest that a GpsB-associated complex orchestrates PG biosynthesis and remodelling in S. pneumoniae.

Indexed as

Bacterial ProteinsCell DivisionPenicillin-Binding ProteinsPeptidoglycanSerine-Type D-Ala-D-Ala CarboxypeptidaseStreptococcus pneumoniaeCell WallHumansPeptidyl TransferasesProtein BindingBacterial ProteinsPBP1a protein, Streptococcus pneumoniaePenicillin-Binding ProteinsPeptidoglycanPeptidyl TransferasesSerine-Type D-Ala-D-Ala Carboxypeptidase

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.